The US Patent Office has granted the fourth FemPulse patent (#9,381,351). This broad patent grants claims regarding implantation and stimulation of nerves within the peritoneal cavity. With its extensive patent portfolio, FemPulse is uniquely positioned to advance the field of wearable neuromodulation therapy for Overactive Bladder.
